Featured by Newsweek & World Class Media Outlets

Interviews

Industry

Mike Finelli
Mike Finelli
Chief Technology and Innovation Officer
Syensqo
2024-04-02

Scaling biotechnological processes from lab to industrial scale represents a significant challenge in the industry, especially given the chemical industry's demand for materials in large quantities.

READ MORE
Mike Guerra
Mike Guerra
President & CEO
California Life Sciences
2024-04-01

California's life sciences industry and Silicon Valley share a close and synergistic relationship, especially in the realms of funding and technological innovation.

READ MORE
Jeff Elton
Jeff Elton
CEO
ConcertAI
2024-04-01

ConcertAI operates at the intersection of healthcare and technology, acting as a neutral intermediary between healthcare providers and biomedical innovators.

READ MORE
Asit Parikh
Asit Parikh
President & CEO
MOMA Therapeutics
2024-03-28

The investment landscape for life sciences, including for companies like MOMA, reflects both challenges and opportunities.

READ MORE
Marino Garcia
Marino Garcia
CEO
Dianthus Therapeutics
2024-03-28

Our understanding of autoimmune diseases has improved significantly, thanks in part to increased investment and research in this domain.

READ MORE
William Humphries
William Humphries
CEO
Alcami Corporation
2024-03-28

Since joining Alcami in June 2023, I have focused on building upon the legacy of my predecessor, Pat Walsh, and expanding each of our operational pillars.

READ MORE
Bertrand Ducrey
Bertrand Ducrey
CEO
Debiopharm
2024-03-27

Debiopharm's global outreach is extensive, and we actively seek opportunities for collaboration worldwide.

READ MORE
Dr. Yuelei Shen
Dr. Yuelei Shen
Chairman of the Board, President & CEO
Biocytogen
2024-03-27

Our two main businesses are animals and therapeutic antibodies. In the animal sector, we offer a unique product, BioMice models, which are ready-to-use, gene-edited animal models available for immediate order.

READ MORE
Dr. Marra, and Dr. Langley
Dr. Marra, and Dr. Langley
Council of Expert Advisors
CEA
2024-03-27

Investments by the Government of Canada should be optimally leveraged for Canada’s longer-term health emergency preparedness, while ensuring that domestically the sector continues to innovate and grow in a manner that is sustainable in the inter-emergency period.

READ MORE
David Wellis
David Wellis
CEO
Excellos
2024-03-26

Our partnership with TC BioPharm, a Scottish company aiming to enter the U.S. market, involves using our facilities for cell collection and manufacturing.

READ MORE